Asset Details
Do you wish to reserve the book?
The multiple roles of nerve biopsy in the diagnosis and prognosis of suspected immune neuropathies
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The multiple roles of nerve biopsy in the diagnosis and prognosis of suspected immune neuropathies
Do you wish to request the book?
The multiple roles of nerve biopsy in the diagnosis and prognosis of suspected immune neuropathies
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The multiple roles of nerve biopsy in the diagnosis and prognosis of suspected immune neuropathies
2024
Overview
Introduction
The value of a sural nerve biopsy for the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is controversial. Evidence-based recommendations for its implementation are lacking. We investigated factors leading to biopsy and analyzed biopsy outcomes and consequences, assessed the predictability of biopsy outcomes through clinical parameters to avoid unnecessary biopsies, and compared results with electrophysiological and clinical severity to determine their prognostic value.
Methods
190 sural nerve biopsies were analyzed in two cohorts. One consisted of 163 biopsies and the second of 72 biopsies from the prospective Immune-mediated Neuropathies Biomaterial and Data registry (INHIBIT). Both have an intersection of 45 patients. 75 data sets from patients without biopsy were used. Analysis of nerve conduction studies, treatment, overall disability sum score (ODSS), biopsy outcomes, and diagnosis was performed.
Results
51% of biopsied patients received the diagnosis CIDP (77% fulfilled EFNS/PNS criteria), 21% were not CIDP typical, and 27% were unspecific. Biopsied patients responded less frequently to immunotherapies at time of biopsy than non-biopsied patients (
p
= 0.003). Immunotherapy was initiated more frequently after biopsy (
p
< 0.001) and more often with intravenous immunoglobulins (
p
< 0.0001). 76% of all biopsied patients met the electrophysiological criteria for CIDP. Sensory nerve action potential amplitudes of 0 µV still provide 73% of histological diagnostic value. Histologic signs of degeneration predicted ODSS worsening after 1 year (
p
= 0.028) but disease severity did not correlate with histological damage severity.
Discussion
The main indication for nerve biopsy was the treatment of refractory cases of autoimmune neuropathies with the therapeutic consequence of treatment initiation or escalation. Sural biopsy also provided prognostic information. Even with extinguished sural SNAP, the biopsy can still have diagnostic value.
Publisher
Springer Berlin Heidelberg,Springer Nature B.V
Subject
/ Adult
/ Aged
/ Biopsy
/ Female
/ Humans
/ Male
/ Medicine
/ Neural Conduction - physiology
/ Patients
/ Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - diagnosis
/ Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - pathology
/ Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - physiopathology
We currently cannot retrieve any items related to this title. Kindly check back at a later time.